LRRC3B and its promoter hypomethylation status predicts response to anti-PD-1 based immunotherapy
Article in Frontiers in Immunology (January 2023)
The most recent citing publications are shown below. View all 6 publications that cite this research output on Dimensions.
Article in Frontiers in Immunology (January 2023)
Article in Frontiers in Oncology (June 2021)
Article in Clinical Epigenetics (October 2020)